99 related articles for article (PubMed ID: 35784359)
1. Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency.
Goda V; Kriván G; Kulcsár A; Gönczi M; Tasnády S; Matula Z; Nagy G; Bekő G; Horváth M; Uher F; Szekanecz Z; Vályi-Nagy I
Front Immunol; 2022; 13():907125. PubMed ID: 35784359
[TBL] [Abstract][Full Text] [Related]
2. Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Fidler S; Fox J; Tipoe T; Longet S; Tipton T; Abeywickrema M; Adele S; Alagaratnam J; Ali M; Aley PK; Aslam S; Balasubramanian A; Bara A; Bawa T; Brown A; Brown H; Cappuccini F; Davies S; Fowler J; Godfrey L; Goodman AL; Hilario K; Hackstein CP; Mathew M; Mujadidi YF; Packham A; Petersen C; Plested E; Pollock KM; Ramasamy MN; Robinson H; Robinson N; Rongkard P; Sanders H; Serafimova T; Spence N; Waters A; Woods D; Zacharopoulou P; Barnes E; Dunachie S; Goulder P; Klenerman P; Winston A; Hill AVS; Gilbert SC; Carroll M; Pollard AJ; Lambe T; Ogbe A; Frater J
Clin Infect Dis; 2023 Jan; 76(2):201-209. PubMed ID: 36196614
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Wei J; Pouwels KB; Stoesser N; Matthews PC; Diamond I; Studley R; Rourke E; Cook D; Bell JI; Newton JN; Farrar J; Howarth A; Marsden BD; Hoosdally S; Jones EY; Stuart DI; Crook DW; Peto TEA; Walker AS; Eyre DW;
Nat Med; 2022 May; 28(5):1072-1082. PubMed ID: 35165453
[TBL] [Abstract][Full Text] [Related]
4. Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Murray SM; Barbanti M; Campbell C; Brown A; Chen L; Dhanapal J; Tseu B; Pervaiz O; Peters L; Springett S; Danby R; Adele S; Phillips E; Malone T; Amini A; Stafford L; Deeks AS; Dunachie S; Klenerman P; Peniket A; Barnes E; Kesavan M
Br J Haematol; 2022 Aug; 198(4):668-679. PubMed ID: 35655410
[TBL] [Abstract][Full Text] [Related]
5. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.
Capuano C; De Federicis D; Ciuti D; Turriziani O; Angeloni A; Anastasi E; Giannini G; Belardinilli F; Molfetta R; Alvaro D; Palmieri G; Galandrini R
Front Immunol; 2023; 14():1285203. PubMed ID: 38045702
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Barnes E; Goodyear CS; Willicombe M; Gaskell C; Siebert S; I de Silva T; Murray SM; Rea D; Snowden JA; Carroll M; Pirrie S; Bowden SJ; Dunachie SJ; Richter A; Lim Z; Satsangi J; Cook G; Pope A; Hughes A; Harrison M; Lim SH; Miller P; Klenerman P; ; Basu N; Gilmour A; Irwin S; Meacham G; Marjot T; Dimitriadis S; Kelleher P; Prendecki M; Clarke C; Mortimer P; McIntyre S; Selby R; Meardon N; Nguyen D; Tipton T; Longet S; Laidlaw S; Orchard K; Ireland G; ; Thomas D; Kearns P; Kirkham A; McInnes IB;
Nat Med; 2023 Jul; 29(7):1760-1774. PubMed ID: 37414897
[TBL] [Abstract][Full Text] [Related]
7. Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic.
Costanzo GAML; Deiana CM; Sanna G; Perra A; Campagna M; Ledda AG; Coghe F; Palmas V; Cappai R; Manzin A; Chessa L; Del Giacco S; Firinu D
J Clin Immunol; 2023 Dec; 44(1):12. PubMed ID: 38129351
[TBL] [Abstract][Full Text] [Related]
8. Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production.
Müller M; Volzke J; Subin B; Müller S; Sombetzki M; Reisinger EC; Müller-Hilke B
BMC Med; 2022 Jan; 20(1):29. PubMed ID: 35042529
[TBL] [Abstract][Full Text] [Related]
9. Comparable CD8
Tranter E; Frentsch M; Hütter-Krönke ML; Vuong GL; Busch D; Loyal L; Henze L; Rosnev S; Blau IW; Thiel A; Beule D; Bullinger L; Obermayer B; Na IK
J Med Virol; 2024 Mar; 96(3):e29539. PubMed ID: 38516755
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers.
Phillips E; Adele S; Malone T; Deeks A; Stafford L; Dobson SL; Amini A; Skelly D; Eyre D; Jeffery K; Conlon CP; Dold C; Otter A; D'Arcangelo S; Turtle L; ; Klenerman P; Barnes E; Dunachie SJ
Clin Exp Immunol; 2022 Jul; 209(1):90-98. PubMed ID: 35522978
[TBL] [Abstract][Full Text] [Related]
11. Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.
Gardner J; Abrams ST; Toh CH; Parker AL; Lovatt C; Nicolson PLR; Watson SP; Grice S; Hering L; Pirmohamed M; Naisbitt DJ
NPJ Vaccines; 2024 Jun; 9(1):99. PubMed ID: 38839821
[TBL] [Abstract][Full Text] [Related]
12. T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.
Zonozi R; Walters LC; Shulkin A; Naranbhai V; Nithagon P; Sauvage G; Kaeske C; Cosgrove K; Nathan A; Tano-Menka R; Gayton AC; Getz MA; Senjobe F; Worrall D; Iafrate AJ; Fromson C; Montesi SB; Rao DA; Sparks JA; Wallace ZS; Farmer JR; Walker BD; Charles RC; Laliberte K; Niles JL; Gaiha GD
Sci Transl Med; 2023 Nov; 15(724):eadh4529. PubMed ID: 38019932
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional mitochondria, disrupted levels of reactive oxygen species, and autophagy in B cells from common variable immunodeficiency patients.
Berman-Riu M; Cunill V; Clemente A; López-Gómez A; Pons J; Ferrer JM
Front Immunol; 2024; 15():1362995. PubMed ID: 38596676
[TBL] [Abstract][Full Text] [Related]
14. ChAdOx1 nCoV-19 vaccination generates spike-specific CD8
Foster WS; Newman J; Thakur N; Spencer AJ; Davies S; Woods D; Godfrey L; Ross SH; Sharpe HJ; Richard AC; Bailey D; Lambe T; Linterman MA
Immunol Cell Biol; 2023 Jul; 101(6):479-488. PubMed ID: 36975169
[TBL] [Abstract][Full Text] [Related]
15. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19.
Ameratunga R; Longhurst H; Steele R; Lehnert K; Leung E; Brooks AES; Woon ST
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3575-3583. PubMed ID: 34182162
[TBL] [Abstract][Full Text] [Related]
16. Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
Ogbe A; Pace M; Bittaye M; Tipoe T; Adele S; Alagaratnam J; Aley PK; Ansari MA; Bara A; Broadhead S; Brown A; Brown H; Cappuccini F; Cinardo P; Dejnirattisai W; Ewer KJ; Fok H; Folegatti PM; Fowler J; Godfrey L; Goodman AL; Jackson B; Jenkin D; Jones M; Longet S; Makinson RA; Marchevsky NG; Mathew M; Mazzella A; Mujadidi YF; Parolini L; Petersen C; Plested E; Pollock KM; Rajeswaran T; Ramasamy MN; Rhead S; Robinson H; Robinson N; Sanders H; Serrano S; Tipton T; Waters A; Zacharopoulou P; Barnes E; Dunachie S; Goulder P; Klenerman P; Screaton GR; Winston A; Hill AV; Gilbert SC; Carroll M; Pollard AJ; Fidler S; Fox J; Lambe T; Frater J
JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35192543
[TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients.
Konuma T; Hamatani-Asakura M; Nagai E; Adachi E; Kato S; Isobe M; Monna-Oiwa M; Takahashi S; Yotsuyanagi H; Nannya Y
Int J Hematol; 2024 Jun; ():. PubMed ID: 38842630
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield).
Dandu H; Goel A; Kumar M; Malhotra HS; Katiyar H; Agarwal M; Kumar N; Pandey P; Rani S; Yadav G
Clin Exp Med; 2024 Jan; 24(1):24. PubMed ID: 38280060
[TBL] [Abstract][Full Text] [Related]
19. Acute exercise increases immune responses to SARS CoV-2 in a previously infected man.
Baker FL; Smith KA; Zúñiga TM; Batatinha H; Niemiro GM; Pedlar CR; Burgess SC; Katsanis E; Simpson RJ
Brain Behav Immun Health; 2021 Dec; 18():100343. PubMed ID: 34514439
[TBL] [Abstract][Full Text] [Related]
20. A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes.
Milito C; Firinu D; Bez P; Villa A; Punziano A; Lagnese G; Costanzo G; van Leeuwen LPM; Piazza B; Deiana CM; d'Ippolito G; Del Giacco SR; Rattazzi M; Spadaro G; Quinti I; Scarpa R; Dalm VASH; Cinetto F
Front Immunol; 2023; 14():1093385. PubMed ID: 36845159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
